Get 40% Off
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2?Unlock full list

GSK plc (GSK)

Currency in GBP

GSK Comments

My first experience with the Investor's Online was not great, I didn't received honest and open advice from those investor's, during my transfer process I wasn't informed of the progress all the way, from the few weeks I started investing through online, All the consultants I have ever dealt with have been friendly and i was introduce to this man whom is very helpful and efficient, Thank you sir. his waspp ÷195/1367/6556........ 0550500502020205005000686886686886686686868686868686886868686868866863535353535355335353555359090909909090090909090909090909009090900909090909090909090909090901010101001011010011010101010101011010100101010101010101011001010101010645454845454878754845454875454875454545454845754875487548754548754548454845454554545454875454545454545555888787545487545454422121221222454544544575787548454545454555151212121212422445544554455454544545545544555454554555455454515151515115454545454521121215844448484884848484848454888
as of 14 Mar 23, anyone buy or sell? and why
my client wants to buy a young politician willing to deprive her country and then franchise a new store for the washing machines foundation
Zantac case ruled in GSK favour, hence the rise
target price 2290£ according to zone bourse
1st malaria vaccine approved by WHO. hopefully good news for the stock. definitely good for the developing world!
who the f dislikes that! lol
Been In GSK since February and wearing almost a 15% gain which i'm pretty chuffed about , not sure what you guys think about GSK going into the future but i'm pretty happy with these returns and am thinking about investing in a PRE IPO called SpectrumX which i have seen on the homepage of LSE and the Sunday times. SpectrumXare leaders in proprietary formulations of HOCL, so looks promising for the future of pharmaceuticals. Have not dabbled with Pre IPOS so wanted to see what you guys think?
to the moon!
Already mooned now buy back at 1300
Good old GSK. Never fails to disappoint.
AMAZING....great news, good comes +2% to -0.7%....I`m done, I`m out
As i said before this company does not understand competitive performance - radical change needed - one off hitting earnings forecast does not mean anything
setting my buys at 12.5
GSK will invent the vaccine of immortality
Will not deliver on results - never does actually - the plans are all nice on paper - but its all just a financial excercise - the forecasts especially on oncology but not only are not real
glx is about to split of the consumer division .
Stock's been on fire these past 2 days. What's the driver?
Anticipation that the briefing on the proposed split on 25 June will suggest an unlocking of value. GSK is a lame duck in the Covid race and in many other aspects, so also hope that the breakup will trigger bids for the separate businesses.
Best drug company there is.
shall go over 15 before 23 June
Pharma sector will benefit the most 2021-2022, just wait for quartely reports.
Walmsley has to go. As a CEO she is a train crash - how can a leading player in pharma specialising in vaccines, not be the leading light in a pandemic, with its share price following the stellar performance of AZ. Elliot management can see the value of GSK improving at least 30% when Walmsley is shown the door
As someone that know GSK very well i can tell you - you cannot be more right - she has no idea what she is doing
Which is the target in 1 year time? Now it is 1,37
One thing i can tell you - if they remove Emma then thjs will fly - before thst happens this is dead - she has no idea of how to run a competitive business - dreadful performance - IPT
Bullish consolidation. Next move coming.
I'm waiting the next results (Next week). What do you think what will happen with the price? the company results will be good or not? Thanks!
Haven't been bad in the past, reliable business. At least they have earnings compared to many stonks.
When can we sell?
Told you so. More buyers than sellers.
So that's why it rises
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.